Literature DB >> 20698450

A high prevalence of Dupuytren's disease in Flanders.

Ilse Degreef1, Luc De Smet.   

Abstract

Dupuytren's disease has been the subject of numerous epidemiological surveys attempting to expand our knowledge on its origin and spread. In Flanders, although numerous studies on surgical outcome have been reported, information on prevalence of Dupuytren's disease is lacking. Therefore, Flanders' population in a non-hospital environment was studied by a clinical evaluation performed by a single hand specialist. Five different market places spread geographically in the 5 Flemish provinces of Belgium were visited to examine the hands of randomly chosen individuals over 50 years old visiting the market. In all, 500 people were examined; Dupuytren's disease was found to be present in 32% of the population. Nodules without finger contractures (stage 1) were seen in 24% of the population, in comparable proportions in males (28%) and females (20%). However, finger contractures (stage 2) were seen in 8%, significantly more often in males (11%) than in females (4%). The prevalence of stage 1 is somewhat lower in individuals over 80 years old. In men, the incidence of stage 2 was found to increase with age. These findings were compared with literature data on the prevalence of Dupuytren's disease in other countries and populations. It appears that, similar to northern Europe, Dupuytren's disease is also a common disease in Flanders.

Entities:  

Mesh:

Year:  2010        PMID: 20698450

Source DB:  PubMed          Journal:  Acta Orthop Belg        ISSN: 0001-6462            Impact factor:   0.500


  9 in total

1.  WT1 expression is increased in primary fibroblasts derived from Dupuytren's disease tissues.

Authors:  Justin Crawford; Christina Raykha; Daevina Charles; Bing Siang Gan; David B O'Gorman
Journal:  J Cell Commun Signal       Date:  2015-06-30       Impact factor: 5.782

2.  Epidemiological profile of Dupuytren's disease in Taiwan (Ethnic Chinese): a nationwide population-based study.

Authors:  Chin-Choon Yeh; Kuo-Feng Huang; Chung-Han Ho; Kuan-Ting Chen; Cheng Liu; Jhi-Joung Wang; Chin-Chen Chu
Journal:  BMC Musculoskelet Disord       Date:  2015-02-10       Impact factor: 2.362

3.  Association between Stenosing Tenosynovitis and Dupuytren's Contracture in the Hand.

Authors:  Kai Yang; Michael Gehring; Savo Bou Zein Eddine; Patrick Hettinger
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-01-11

Review 4.  Recent advances in the understanding of Dupuytren's disease.

Authors:  Thomas Layton; Jagdeep Nanchahal
Journal:  F1000Res       Date:  2019-02-28

5.  Ethnic differences in prevalence of Dupuytren disease can partly be explained by known genetic risk variants.

Authors:  Sophie A Riesmeijer; Paul M N Werker; Ilja M Nolte
Journal:  Eur J Hum Genet       Date:  2019-07-30       Impact factor: 4.246

6.  Echogenicity of Dupuytren's nodules is correlated to myofibroblast load and nodule hardness.

Authors:  Sanne Molenkamp; Whangzao Song; Marjolein Bloembergen; Dieuwke C Broekstra; Paul M N Werker
Journal:  J Hand Surg Eur Vol       Date:  2021-10-07

7.  Long-Term Radiographic Adaptations to Stress of High-Level and Recreational Rock Climbing in Former Adolescent Athletes: An 11-Year Prospective Longitudinal Study.

Authors:  Volker Rainer Schöffl; Phillip Max Hoffmann; Andreas Imhoff; Thomas Küpper; Isabelle Schöffl; Thomas Hochholzer; Stefan Hinterwimmer
Journal:  Orthop J Sports Med       Date:  2018-09-05

8.  Examiners' influence on the measured active and passive extension deficit in finger joints affected by Dupuytren disease.

Authors:  Jesper Nordenskjöld; Stina Brodén; Isam Atroshi
Journal:  BMC Med Res Methodol       Date:  2018-10-29       Impact factor: 4.615

9.  The worldwide prevalence of the Dupuytren disease: a comprehensive systematic review and meta-analysis.

Authors:  Nader Salari; Mohammadbagher Heydari; Masoud Hassanabadi; Mohsen Kazeminia; Nikzad Farshchian; Mehrdad Niaparast; Yousef Solaymaninasab; Masoud Mohammadi; Shamarina Shohaimi; Alireza Daneshkhah
Journal:  J Orthop Surg Res       Date:  2020-10-28       Impact factor: 2.359

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.